<?xml version="1.0" encoding="UTF-8"?>
<p>Nausea, vomiting, and abdominal pain were the most common gastrointestinal complications in our patients, and the incidence rates were not different between the groups. Although two cases experienced slight elevation in serum amylase and lipase levels, in further evaluations, no pancreatitis was confirmed. COVID-19 can cause several gastrointestinal symptoms. However, gastrointestinal symptoms that started after the hospital admission may be related to the medications. The incidence rates of AKI and hepatic impairment were not significantly different between the IFN and the control groups. Both renal and liver injuries can be COVID-19-associated organ dysfunction (
 <xref rid="B43" ref-type="bibr">43</xref>). The nephrotoxicity of medications like antibiotics and furosemide (which were frequently prescribed in our patients) and hepatotoxicity of antiviral agents also should be taken into account. No case of hepatotoxicity that led to the discontinuation of interferon was detected. Indirect hyperbilirubinemia is one of the adverse effects of atazanavir-ritonavir (
 <xref rid="B44" ref-type="bibr">44</xref>).
</p>
